Finance
S&P 500 7,757.17 +44.60 +0.58% Dow 52,856.09 +360.19 +0.69% Nasdaq 26,702.86 +278.04 +1.05% NYSE Composite 24,253.12 +62.52 +0.26% Russell 2000 2,781.02 +7.60 +0.27% VIX 18.57 +1.89 +11.33%

HRGN · Harvard Apparatus Regenerative Technology, Inc.

OTC MARKETS - Real Time Price • USD

Harvard Apparatus Regenerative Technology Inc (HRGN)

OTC MARKETS Biotechnology
Move probability → Options chain →
$2.06 -0.14 (-6.36%)
● Pre-market
DAY'S RANGE $2.06
$2.06 $2.06
52-WEEK RANGE $2.06
$0.96 $2.46

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$41.8M
P/E (TTM1)—
EPS2 (TTM)$-0.39
Div Yield—
Beta3-0.50
Volume—
Open2.06
Prev Close2.20
Bid / Ask— / —
Next Earnings 2026-11-05

Analyst Recommendations

Strong buy 0 Buy 0 Hold 3 Sell 1 Strong sell 2

Aggregate ratings for 2021-12-01 (6 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
HRGN +19.57%
vs S&P 500 +15.81%
1-YEAR RETURN
HRGN -9.76%
vs S&P 500 -20.71%
6-MONTH RETURN
HRGN +18.92%
3-MONTH RETURN
HRGN +46.67%

Valuation Measures & Ratios

Enterprise Value4$41.9M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)42.55
Price / Book7320.54
EV4 / Revenue42.70
EV4 / EBITDA—
Profit Margin-680.45%
Operating Margin-683.30%
Return on Equity (ROE8)-786.37%
Return on Assets (ROA9)-307.01%
Avg Volume (3M)2,280
Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short625
Change from Prior Settlement-84.04%
% of Float—
Days to Cover (Short Ratio)1.00

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

  • Revenue growth is 30.6% on the provider's reported measure. Finnhub fundamentals ↗
  • Latest SEC filing is Form 4, filed 2026-09-25; review it for current changes and risks. SEC EDGAR ↗

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

No accessible free API for these — links go to the source directly.

Morningstar MarketBeat

Financials

Income statement

Line item Jun '26Mar '26Sep '25Jun '25Mar '25Sep '24Jun '24Mar '24
Revenue $414.0K $226.0K $123.0K $317.0K $45.0K $59.0K $56.0K $57.0K
Gross profit — — — — — — — —
Operating income -$1.7M -$1.6M -$1.7M -$1.8M -$1.7M -$1.9M -$2.5M -$2.0M
Net income -$1.7M -$1.6M -$1.7M -$1.8M -$1.7M -$1.9M -$2.5M -$2.0M
EPS (diluted) — — — — — $-0.12 $-0.18 $-0.15
EPS (basic) $-0.10 $-0.09 $-0.10 $-0.11 $-0.10 $-0.12 $-0.18 $-0.15

Balance sheet

Line item Jun '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Total assets $1.7M $1.7M $1.8M $2.7M $2.5M $2.1M $3.4M $4.4M
Total liabilities $3.1M — $1.7M $1.6M $992.0K $1.4M $1.4M $1.2M
Stockholders' equity -$1.4M — $92.0K $1.1M $1.6M $761.0K $2.0M $3.2M
Total current assets $789.0K — $873.0K $1.8M $1.6M $1.1M $2.3M $3.2M
Total current liabilities $3.0M — $1.7M $1.5M $876.0K $1.2M $1.2M $1.0M
Cash & equivalents $351.0K $351.0K $419.0K $1.4M $1.3M $786.0K $1.7M $2.5M

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$569.0K -$937.0K -$664.0K -$1.5M -$941.0K -$758.0K -$1.1M -$1.5M
Investing cash flow — — — — — — $0 —
Financing cash flow $500.0K — $700.0K $2.0M $0 $0 $0 $4.9M
Free cash flow — — — — — — -$1.1M —
Capital expenditures — — — — — — $0 —
Share-based compensation $223.0K $632.0K $493.0K $495.0K $537.0K $485.0K $708.0K $562.0K

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding HRGN as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2024-06-21 to 2026-09-15

Recent transactions

  • Insiders have net bought 368,630 shares over the last 182 days, across 2 purchases and 0 sales.
  • Most recent: He Junli (CEO) — Open market purchase of 6,725 shares on 2026-09-15.

Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.

Insider purchases & sales, last 6 months

Purchases (open market)368,630 sh(2 txns)
Sales (open market)0 sh(0 txns)
Net Shares+368,630

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
He JunliCEOOpen market purchase2026-09-156,725

Recent transactions

DateInsiderTitleTransactionSharesPrice
2026-09-15He JunliCEOOpen market purchase 6,725$2.15
2026-09-11He JunliCEODerivative conversion 683,725$1.05
2026-09-11He JunliCEOOpen market purchase 361,905$1.05
2025-11-25He JunliCEOOpen market purchase 3,000$1.70
2025-09-30He JunliCEOOpen market purchase 300$1.98
2025-09-02He JunliCEOOpen market purchase 11,225$1.85
2025-08-21He JunliCEOOpen market purchase 4,050$1.72
2024-12-24He JunliCEOOpen market purchase 2,299$2.87

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-22 04:29 UTC

FiledFormReport periodOfficial filing
2026-09-2542026-09-11 View on SEC.gov →
2026-09-148-K2026-09-11 View on SEC.gov →
2026-08-1310-Q2026-06-30 View on SEC.gov →
2026-08-1142026-07-21 View on SEC.gov →
2026-08-038-K2026-05-08 View on SEC.gov →
2026-06-248-K2026-06-18 View on SEC.gov →
2026-05-1310-Q2026-03-31 View on SEC.gov →
2026-04-288-K2026-04-27 View on SEC.gov →
2026-04-158-K2026-04-13 View on SEC.gov →
2026-03-1910-K2025-12-31 View on SEC.gov →
2026-01-068-K2025-12-30 View on SEC.gov →
2025-12-0142025-11-25 View on SEC.gov →

Headlines about HRGN (Harvard Apparatus Regenerative Technology, Inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist